does kaiser permanente cover glp-1 drugs A Closer Look: Medications for Weight Loss Denial for GLP-1 : r/KaiserPermanente
Description
In addition, the American Diabetes Association (ADA) also recommends weight loss based on intensive lifestyle interventions to achieve optimal control of traditional cardiovascular risk factors in overweight or obese adults with type 2 diabetes [16]
Major cardiovascular outcome trials, including LEADER, SUSTAIN-6, and REWIND, followed patients for several years
Novo Nordisk is conducting a clinical trial to study safety outcomes of infants born to pregnant people exposed to Wegovy and other weight loss medications during pregnancy
( Epub 2018/11/15 )
doi: 10.3350/cmh.2025.0744, 51
